Virological Predictors of Response to Retreatment in Hepatitis C Genotype 2 Infected Patients-Reference-Cited by-同舟云学术

Virological Predictors of Response to Retreatment in Hepatitis C Genotype 2 Infected Patients

Published:2013-03-19 Issue:3 Volume:8 Page:e58882
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Huang Chung-Feng,Dai Chia-Yen,Yeh Ming-Lun,Huang Jee-Fu,Huang Ching-I,Hsieh Ming-Yen,Lin Zu-Yau,Chen Shinn-Cherng,Wang Liang-Yen,Juo Suh-Hang Hank,Chuang Wan-Long,Lin Yi-Ching,Yu Ming-Lung

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. Viral hepatitis infections in southern Taiwan: a multicenter community-based study;JF Yang;Kaohsiung J Med Sci,2010

2. Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1,386-patient study from Taiwan;JF Huang;Aliment Pharmacol Ther,2007

3. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan;ML Yu;Antivir Ther,2006

4. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases;MG Ghany;Hepatology,2011

5. A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C. Gut;ML Yu,2007

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of treatment-experienced hepatitis C patients with poor cost-effectiveness of pegylated interferon plus ribavirin from a real-world cohort;Journal of the Formosan Medical Association;2018-01

2. Hepatitis C treatment from “response-guided” to “resource-guided” therapy in the transition era from interferon-containing to interferon-free regimens;Journal of Gastroenterology and Hepatology;2017-07-28

3. Seroprevalence and clinical characteristics of viral hepatitis in transfusion-dependent thalassemia and hemophilia patients;PLOS ONE;2017-06-09

4. APASL consensus statements and recommendation on treatment of hepatitis C;Hepatology International;2016-04-29

5. Elevated on-treatment levels of serum IFN-gamma is associated with treatment failure of peginterferon plus ribavirin therapy for chronic hepatitis C;Scientific Reports;2016-03